|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5377 | |
| C07D 471/04 | |||
| A61P 25/24 |
| (11) | Patento numeris | 3338781 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18154256.4 |
| Europos patento paraiškos padavimo data | 2013-05-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261651669 P | 2012-05-25 | US | |
| 201261691083 P | 2012-08-20 | US | |
| 201261715907 P | 2012-10-19 | US | |
| 201361759520 P | 2013-02-01 | US | |
| 201361781629 P | 2013-03-14 | US |
| (72) |
HUNT, Hazel, GB
JOHNSON, Tony, GB
RAY, Nicholas, GB
WALTERS, Iain, GB
|
| (73) |
Corcept Therapeutics Incorporated,
149 Commonwealth Drive, Menlo Park, CA 94025,
US
|
| (54) | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |
| HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |